Evidence map›Paper›PMID 40264033›Full record

ArticleBMC ophthalmology2025

Phaeoacremonium iranianum - a new corneal pathogen.

Xiaona Liu, Xiuhai Lu, Juanjuan Zheng, Shujuan Liu, Man Li

Abstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaona LiuClinical Laboratory, Jinan Mingshui Eye Hospital, Longquan Road 5601, Zhangqiu District, Jinan, China.
Xiuhai LuClinical Laboratory, Shandong Eye Hospital, Jingsi Road 372, Huaiyin District, Jinan, China.
Juanjuan ZhengClinical Laboratory, Jinan Mingshui Eye Hospital, Longquan Road 5601, Zhangqiu District, Jinan, China.
Shujuan LiuClinical Laboratory, Jinan Mingshui Eye Hospital, Longquan Road 5601, Zhangqiu District, Jinan, China.
Man LiClinical Laboratory, Jinan Mingshui Eye Hospital, Longquan Road 5601, Zhangqiu District, Jinan, China. 420926714@qq.com.

Funding

Jinan Mingshui Eye Hospital, Project approval within the hospital 2025-1-05
6 · The paper itself

Abstract

backgroundPhaeoacremonium is typically found in the environment and can cause diseases in woody plants. It is rarely responsible for infections in humans. CASE PRESENTATION: In this report, we present a case of corneal infection caused by Phaeoacremonium iranianum. Caused a fan-shaped grayish-white ulcer measuring approximately 4 mm×3 mm inferior nasal cornea. The ulcer appeared relatively dry, with noticeable swelling and cloudiness in the surrounding cornea. The visual acuity after infection was 0.25. We started an aggressive antifungal therapy. Our antifungal susceptibility testing revealed the Minimum Inhibitory Concentration of anifengin was 4 µg/ml, Micafengin and carpofungin exceeding 8 µg/ml, fluorocytosine was 32 µg/ml, posaconazole was 1 µg/ml, voriconazole was 0.5 µg/ml, itraconazole was 2 µg/ml, fluconazole was 64 µg/ml, and amphotericin was 0.05 µg/ml. The patient underwent keratectomy combined with antifungal therapy. A month later, the conjunctiva of the right eye was congested, and a 4*4 mm corneal opacity was visible inferior nasal cornea, with local obvious thinning and a little keratic precipitates on the inner skin, and the infection has been controlled.

conclusionsWe detail the progression and treatment of this infection to contribute to the clinical understanding and management of such cases.

Indexed as

AscomycotaCorneal UlcerEye Infections, FungalMycosesAntifungal AgentsCorneaHumansMicrobial Sensitivity TestsAntifungal AgentsFungusKeratitisPhaeoacremonium Iranianum

Identifiers

PMID40264033
PMCPMC12013100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.